Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

539.97

575.21

531.36

572.64

621.75

Operating profit

152.55

182.61

110.71

181.87

203.45

Interest

2.86

2.73

2.87

2.53

3.84

Gross profit

185.54

215.95

141.30

210.72

227.02

EPS (Rs)

28.41

32.56

20.44

28.34

32.93

Other income

35.85

36.07

33.46

31.38

27.41

Stock adjustment

-43.27

41.86

-17.11

-5.62

47.40

Raw material

77.23

83.78

86.11

70.67

89.93

Power and fuel

-

-

-

-

-

Employee expenses

89.37

89.80

93.52

65.31

91.69

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

264.09

177.16

258.13

260.41

189.28

Provisions made

-

-

-

-

-

Depreciation

17.55

15.43

15.55

26.41

26.34

Taxation

45.96

51.56

32.22

35.07

50.02

Net profit / loss

129.98

148.96

93.53

129.65

150.66

Extra ordinary item

7.95

-

-

-19.59

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.25

31.75

20.84

31.76

32.72

GPM (%)

32.22

35.33

25.02

34.89

34.97

NPM (%)

22.57

24.37

16.56

21.46

23.21